218 related articles for article (PubMed ID: 28429243)
1. SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway.
Dudenkov TM; Ingle JN; Buzdar AU; Robson ME; Kubo M; Ibrahim-Zada I; Batzler A; Jenkins GD; Pietrzak TL; Carlson EE; Barman P; Goetz MP; Northfelt DW; Moreno-Aspita A; Williard CV; Kalari KR; Nakamura Y; Wang L; Weinshilboum RM
Breast Cancer Res Treat; 2017 Jul; 164(1):189-199. PubMed ID: 28429243
[TBL] [Abstract][Full Text] [Related]
2. Alcohol-related breast cancer in postmenopausal women - effect of CYP19A1, PPARG and PPARGC1A polymorphisms on female sex-hormone levels and interaction with alcohol consumption and NSAID usage in a nested case-control study and a randomised controlled trial.
Kopp TI; Jensen DM; Ravn-Haren G; Cohen A; Sommer HM; Dragsted LO; Tjonneland A; Hougaard DM; Vogel U
BMC Cancer; 2016 Apr; 16():283. PubMed ID: 27102200
[TBL] [Abstract][Full Text] [Related]
3. Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole.
Lunardi G; Piccioli P; Bruzzi P; Notaro R; Lastraioli S; Serra M; Marroni P; Bighin C; Mansutti M; Puglisi F; Porpiglia M; Ponzone R; Bisagni G; Garrone O; Cavazzini G; Clavarezza M; Del Mastro L
Breast Cancer Res Treat; 2013 Jan; 137(1):167-74. PubMed ID: 23129173
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.
Pasqualini JR; Chetrite G; Blacker C; Feinstein MC; Delalonde L; Talbi M; Maloche C
J Clin Endocrinol Metab; 1996 Apr; 81(4):1460-4. PubMed ID: 8636351
[TBL] [Abstract][Full Text] [Related]
5. Effects of
Dempsey JM; Kidwell KM; Gersch CL; Pesch AM; Desta Z; Storniolo AM; Stearns V; Skaar TC; Hayes DF; Henry NL; Rae JM; Hertz DL
Pharmacogenomics; 2019 Jun; 20(8):571-580. PubMed ID: 31190621
[No Abstract] [Full Text] [Related]
6. Aromatase and breast cancer susceptibility.
Probst-Hensch NM; Ingles SA; Diep AT; Haile RW; Stanczyk FZ; Kolonel LN; Henderson BE
Endocr Relat Cancer; 1999 Jun; 6(2):165-73. PubMed ID: 10731105
[TBL] [Abstract][Full Text] [Related]
7. Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Ingle JN; Kalari KR; Barman P; Shepherd LE; Ellis MJ; Goss PE; Buzdar AU; Robson ME; Cairns J; Carlson EE; Eyman Casey A; Hoskin TL; Goodnature BA; Haddad TC; Goetz MP; Weinshilboum RM; Wang L
Pharmacogenet Genomics; 2021 Jan; 31(1):1-9. PubMed ID: 32649577
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk.
Justenhoven C; Schaeffeler E; Winter S; Baisch C; Hamann U; Harth V; Rabstein S; Spickenheuer A; Pesch B; Brüning T; Ko YD; Schwab M; Brauch H
Breast Cancer Res Treat; 2011 Jan; 125(2):563-9. PubMed ID: 20635135
[TBL] [Abstract][Full Text] [Related]
9. SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study.
Reimer T; Kempert S; Gerber B; Thiesen HJ; Hartmann S; Koczan D
BMC Cancer; 2016 May; 16():337. PubMed ID: 27234217
[TBL] [Abstract][Full Text] [Related]
10. Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole.
Ingle JN; Kalari KR; Buzdar AU; Robson ME; Goetz MP; Desta Z; Barman P; Dudenkov TT; Northfelt DW; Perez EA; Flockhart DA; Williard CV; Wang L; Weinshilboum RM
Steroids; 2015 Jul; 99(Pt A):32-8. PubMed ID: 25163006
[TBL] [Abstract][Full Text] [Related]
11. TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.
Liu M; Ingle JN; Fridley BL; Buzdar AU; Robson ME; Kubo M; Wang L; Batzler A; Jenkins GD; Pietrzak TL; Carlson EE; Goetz MP; Northfelt DW; Perez EA; Williard CV; Schaid DJ; Nakamura Y; Weinshilboum RM
Mol Endocrinol; 2013 Apr; 27(4):657-70. PubMed ID: 23518928
[TBL] [Abstract][Full Text] [Related]
12. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
13. An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples.
Geisler J; Ekse D; Helle H; Duong NK; Lønning PE
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):90-5. PubMed ID: 18242079
[TBL] [Abstract][Full Text] [Related]
14. The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.
Lee E; Schumacher F; Lewinger JP; Neuhausen SL; Anton-Culver H; Horn-Ross PL; Henderson KD; Ziogas A; Van Den Berg D; Bernstein L; Ursin G
Breast Cancer Res; 2011 Apr; 13(2):R37. PubMed ID: 21457551
[TBL] [Abstract][Full Text] [Related]
15. Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.
Geisler J; Haynes B; Ekse D; Dowsett M; Lønning PE
J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):27-34. PubMed ID: 17350249
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identifies genetic regulation of oestrone concentrations and association with endometrial cancer risk in postmenopausal women.
Yu C; Bakshi A; Bell RJ; Islam RM; Handelsman DJ; McNeil JJ; Lacaze P; Davis SR
EBioMedicine; 2024 Mar; 101():104997. PubMed ID: 38324981
[TBL] [Abstract][Full Text] [Related]
17. Effect of CYP19 rs6493497 and rs7176005 haplotype status on in vivo aromatase transcription, plasma and tissue estrogen levels in postmenopausal women.
Straume AH; Knappskog S; Lønning PE
J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):69-75. PubMed ID: 21939764
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.
Niemi M; Backman JT; Kajosaari LI; Leathart JB; Neuvonen M; Daly AK; Eichelbaum M; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2005 Jun; 77(6):468-78. PubMed ID: 15961978
[TBL] [Abstract][Full Text] [Related]
19. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
20. Mapping SLCO1B1 Genetic Variation for Global Precision Medicine in Understudied Regions in Africa: A Focus on Zulu and Cape Admixed Populations.
Hoosain N; Pearce B; Jacobs C; Benjeddou M
OMICS; 2016 Sep; 20(9):546-54. PubMed ID: 27631194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
